H.R. 795 · 119th Congress · Health

Pregnancy Is Not an Illness Act of 2025

In committee193 words Introduced Jan 28, 2025 · Latest action Jan 28, 2025

How far it has goneStage 2 of 6
  1. IntroducedJan 28, 2025 Done
  2. CommitteeReferred to Energy and Commerce Current stage
  3. House floorNot yet Not reached yet
  4. Senate floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

This bill prohibits the Food and Drug Administration (FDA) from treating pregnancy as an illness for the purposes of approving any abortion drug or imposing a risk evaluation and mitigation strategy for an abortion drug. The bill also nullifies FDA approval of any abortion drug that relied at all on the treatment of pregnancy as an illness, and specifically nullifies the FDA’s approval of the abortion drug mifepristone in effect before the bill is enacted.

Congressional Research Service · summary of “Introduced in House” version · Jan 28, 2025

Who lobbies on it

2 organizations · 7 filings · Q1 2025–Q3 2026

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. Students for Life Action 4 of 7 quarters
    “Ending Chemical Abortion Act H.R. 692 Born-Alive Abortion Survivors Protection Act H.R. 21 Born-Alive Abortion Survivors Protection Act S. 6 Life at Conception Act H.R. 722 Protecting Life and Taxpayers Act H.R. 272 Defund Planned Parenthood Act H.R. 271 Womens Protection in Telehealth Act H.R 1349 Ultrasounds Saves…”

    Q4 2025 filing · Under $5,000 lobbying spend in 2025, all issues

  2. Susan B Anthony List 3 of 7 quarters
    “Shield Laws Chemical abortion drugs S. 1631, H. R. 5646 - Restoring Safeguards for Dangerous Abortion Drugs Act H.R. 679 - To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes…”

    Q2 2026 filing · $1.1M lobbying spend in 2026 to date, all issues

Organizations that named H.R. 795 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field.

Actions

2 actions · newest first
  1. Jan 28, 2025Referred to the House Committee on Energy and Commerce.
  2. Jan 28, 2025Introduced in House